Wellington Management Group LLP Ascendis Pharma A/S Transaction History

Wellington Management Group LLP

$548 Billion
Q2 2024

A detailed history of Wellington Management Group LLP transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Wellington Management Group LLP holds 2,612,856 shares of ASND stock, worth $331 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,612,856

Previous 2,745,872 4.84%

Holding current value

$331 Million

Previous $415 Million 14.15%

% of portfolio

0.06%

Previous 0.08%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$121.07 - $153.67 $16.1 Million - $20.4 Million	-133,016 Reduced 4.84%	2,612,856 $356 Million
Q1 2024 May 15, 2024	BUY	$123.45 - $159.4 $339 Million - $438 Million	2,745,872 New	2,745,872 $415 Million
Q4 2023 Feb 12, 2024	BUY	$86.1 - $127.36 $280 Million - $414 Million	3,248,293 New	3,248,293 $409 Million
Q3 2023 Nov 14, 2023	BUY	$86.5 - $103.97 $11.1 Million - $13.3 Million	128,272 Added 4.07%	3,277,172 $307 Million
Q2 2023 Aug 14, 2023	BUY	$69.96 - $97.84 $15 Million - $21 Million	215,108 Added 7.33%	3,148,900 $281 Million
Q1 2023 May 12, 2023	SELL	$104.9 - $126.78 $12.6 Million - $15.2 Million	-119,813 Reduced 3.92%	2,933,792 $315 Million
Q4 2022 Feb 13, 2023	SELL	$99.42 - $131.97 $61.5 Million - $81.6 Million	-618,621 Reduced 16.85%	3,053,605 $373 Million
Q3 2022 Nov 14, 2022	BUY	$84.03 - $110.23 $10.3 Million - $13.6 Million	123,089 Added 3.47%	3,672,226 $379 Million
Q2 2022 Aug 15, 2022	SELL	$78.08 - $117.61 $87.2 Million - $131 Million	-1,116,442 Reduced 23.93%	3,549,137 $330 Million
Q1 2022 May 16, 2022	BUY	$102.18 - $135.75 $60.8 Million - $80.8 Million	594,855 Added 14.61%	4,665,579 $548 Million
Q4 2021 Feb 11, 2022	BUY	$127.1 - $169.66 $15.9 Million - $21.3 Million	125,480 Added 3.18%	4,070,724 $548 Million
Q3 2021 Nov 15, 2021	BUY	$112.67 - $176.92 $57.6 Million - $90.4 Million	510,971 Added 14.88%	3,945,244 $629 Million
Q2 2021 Aug 16, 2021	SELL	$121.62 - $145.29 $7.06 Million - $8.44 Million	-58,060 Reduced 1.66%	3,434,273 $452 Million
Q1 2021 May 17, 2021	BUY	$124.92 - $173.33 $11.3 Million - $15.7 Million	90,775 Added 2.67%	3,492,333 $450 Million
Q4 2020 Feb 12, 2021	BUY	$151.2 - $182.76 $22.6 Million - $27.4 Million	149,797 Added 4.61%	3,401,558 $567 Million
Q3 2020 Nov 16, 2020	BUY	$134.29 - $154.32 $197 Million - $226 Million	1,465,470 Added 82.04%	3,251,761 $502 Million
Q2 2020 Aug 14, 2020	BUY	$110.87 - $156.01 $12.9 Million - $18.1 Million	116,145 Added 6.95%	1,786,291 $264 Million
Q1 2020 May 14, 2020	SELL	$97.01 - $145.11 $4.58 Million - $6.85 Million	-47,189 Reduced 2.75%	1,670,146 $188 Million
Q4 2019 Feb 11, 2020	BUY	$91.45 - $139.12 $157 Million - $239 Million	1,717,335 New	1,717,335 $239 Million

Others Institutions Holding ASND

# of Institutions

225

Shares Held

56.6M

Call Options Held

142K

Put Options Held

259K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.07B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Ascendis Pharma A/S Transaction History